These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14440551)

  • 1. [Changes of blood cholesterol and lipid level in atherosclerotic patients treated with a new heparinoid lacking anticoagulant action].
    SABELLA G; DE SIMONE M
    Clin Ter; 1960 Apr; 18():395-412. PubMed ID: 14440551
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of tinnitus and internal ear deafness with a new non-anticoagulant heparinoid, SP 54].
    BACHMANN W
    HNO; 1961 Sep; 9():304-6. PubMed ID: 13863738
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACTION OF A HEPARINOID IN ARTERIOSCLEROTICS UNDER ANTICOAGULANT THROMBOLYTIC TREATMENT].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1879-84. PubMed ID: 14168961
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
    ARGE E
    Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparinoid and heparin; anticoagulant effects of dexulate, a dextran sulfate preparation].
    ARGE E
    Ugeskr Laeger; 1957 Feb; 119(9):248-51. PubMed ID: 13422709
    [No Abstract]   [Full Text] [Related]  

  • 7. A trial with a physiological heparinoid in some sclerotic chorioretinopathies. An evaluation based on serum cholesterol and lipoprotein values and on clinical ocular findings.
    VANNAS S; KRAUSE U
    Acta Ophthalmol (Copenh); 1961; 39():466-74. PubMed ID: 13780180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the hemostatic defect caused by anticoagulants by evaluation of the intensity of the hemorrhage. I. Direct anticoagulants (heparin and synthetic heparinoids)].
    FRANDOLI G
    G Gerontol; 1962 Jul; 10():733-43. PubMed ID: 13959207
    [No Abstract]   [Full Text] [Related]  

  • 9. [ANTICOAGULANT DRUG THERAPY IN MYOCARDIAL INFARCT].
    MATSUOKA S; HOMMA T
    Sogo Rinsho; 1964 Mar; 13():463-71. PubMed ID: 14140834
    [No Abstract]   [Full Text] [Related]  

  • 10. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
    Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
    Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new synthetic anticoagulant (heparinoid) preliminary report of its action in humans.
    SORENSON CW; SEIFTER J; WRIGHT IS
    Bull N Y Acad Med; 1949 Jul; 25(7):448. PubMed ID: 18152256
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of a heparinoid extract on the blood lipoprotein pattern and cholesterol level].
    PERUZY AD; SERENO L
    Rass Fisiopatol Clin Ter; 1957 Dec; 29(12):1363-74. PubMed ID: 13527682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)].
    LEBLOIS J; LESAGE R; RIVET E
    Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic action of heparinoid substance (L. 942) on experimentally induced venous thromboses].
    DEGNI M; de LANGLADA F
    Rev Assoc Med Bras; 1961 Aug; 7():287-90. PubMed ID: 13884866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of anticoagulant therapy with the heparinoid tolerance test].
    JUERGENS J
    Thromb Diath Haemorrh; 1962 Nov; 8():342-54. PubMed ID: 13957971
    [No Abstract]   [Full Text] [Related]  

  • 16. Low molecular weight heparins and heparinoid, a recent development in anticoagulant treatment: application in hemodialysis.
    ten Cate JW; Wilmink JM
    Int J Artif Organs; 1986 Nov; 9(6):397-400. PubMed ID: 2434437
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect in man of a new heparinoid, treburon.
    FIELD JB; RAMSAY GD; ATTYAH AM; STARR P
    J Lab Clin Med; 1953 Feb; 41(2):208-14. PubMed ID: 13035252
    [No Abstract]   [Full Text] [Related]  

  • 18. [RESEARCH ON THE FIBRINOLYTIC AND ANTICOAGULANT ACTION OF A SULFURATED DERIVATIVE OF XYLAN (SYNTHETIC HEPARINOID) WITH A LOW-GRADE POLYMERIZATION].
    CIPOLLI PL; GIBELLI A
    Riv Patol Clin; 1963 Aug; 18():395-403. PubMed ID: 14083551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of heparin, heparin derivatives and heparinoids on blood sugar levels of diabetes mellitus patients].
    Bozadzhieva EK; Markovski SG
    Probl Endokrinol (Mosk); 1978; 24(6):23-30. PubMed ID: 82965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ANTICOAGULANTS. 2. HEPARINS, HAPARINOIDS, RARE EARTHS AND THROMBOLYTICS].
    REPPEL L
    Pharmazie; 1964 Mar; 19():189-96. PubMed ID: 14248782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.